Clinical Trial Update: Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating luteinizing hormone supplementation in GnRH antagonist cycles for ovarian stimulation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Luteinizing Hormone (luteinizing hormone)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Ovarian Stimulation | Phase 3 | Status: COMPLETED